• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A drug experience registry.

作者信息

Resman B H, McLeod D C

出版信息

Am J Hosp Pharm. 1976 Oct;33(10):1051-3.

PMID:973632
Abstract

The Drug Exerience Registry is a system for the recording and filing of drug-related patient events in a readily retrievable form. The purpose of the registry is to accumulate information on adverse drug reactions, unusual therapeutic successes of failures, and other experiences that may be useful for education, research or promotion of rational drug therapy. Data are recorded on case report forms which are categorized by organ-disease system affected, the clinical event and involved drug(s). These are then filed in the clinical event file along with literature synopses that serve as guides in evaluating the incidents and determining proper therapy. A drug file serves as a cross index to the clinical event file and allows one to quickly locate clinical events involving a drug. Both files contain sufficient hospital data to allow later retrieval of additional information if needed.

摘要

相似文献

1
A drug experience registry.
Am J Hosp Pharm. 1976 Oct;33(10):1051-3.
2
Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).用药差错:一项比较PHICO的结案索赔数据与PHICO事件报告趋势系统(PERTS)的分析。
J Clin Pharmacol. 2003 Jul;43(7):754-9.
3
The national registry of drug-induced ocular side effects.国家药物性眼部副作用登记处。
Aust J Ophthalmol. 1984 May;12(2):129-31.
4
[Computerization and the importance of information in health system, as in health care resources registry].[计算机化以及信息在卫生系统中的重要性,如在医疗保健资源登记方面]
Acta Med Croatica. 2005;59(3):251-7.
5
How to anticipate the assessment of the public health benefit of new medicines?如何预测对新药公共卫生效益的评估?
Therapie. 2007 Sep-Oct;62(5):427-35. doi: 10.2515/therapie:2007071. Epub 2008 Jan 19.
6
Adverse reactions to drugs. WHO research centre.
Int J Clin Pharmacol. 1973 Apr;7(2):253-64.
7
The NCI All Ireland Cancer Conference.美国国家癌症研究所全爱尔兰癌症会议。
Oncologist. 1999;4(4):275-277.
8
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
9
Can we rely on public data as a source of information for cancer registry in developing countries?在发展中国家,我们能否将公共数据作为癌症登记的信息来源?
Turk J Gastroenterol. 2005 Sep;16(3):147-9.
10
National scientific registry of organ transplantation: data needs and uses.
Top Health Rec Manage. 1990 Dec;11(2):1-12.